In this drug utilization study, 100 prescriptions were analyzed. A total of 195 antidiabetic drugs prescribed, of which 37.90 % were Biguanides, 22.60 % sulphonylureas, 25.64 % were insulin. DPP-4 Inhibitors were 7.20% , 1.02% were thiazolidinediones (PPARγ activator) and 5.64% were α-Glucosidase inhibitors. Most of the anti- diabetic prescribed were from the essential medicine list. During the study, it was observed that most frequently prescribed anti-diabetic drug classes were biguanides insulin and sulphonylureas and the most frequently prescribed anti-diabetic as monotherapy among them is Biguanides.